Diffuse Intrinsic Pontine Glioma : Clinical Features, Molecular Genetics, and Novel Targeted Therapeutics.

about

Diffuse Intrinsic Pontine Glioma : Clinical Features, Molecular Genetics, and Novel Targeted Therapeutics.

Item

http://www.wikidata.org/entity/Q55285428

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Diffuse Intrinsic Pontine Glio ...... d Novel Targeted Therapeutics.

@en

Diffuse Intrinsic Pontine Glio ...... d Novel Targeted Therapeutics.

@nl

type

Item

label

Diffuse Intrinsic Pontine Glio ...... d Novel Targeted Therapeutics.

@en

Diffuse Intrinsic Pontine Glio ...... d Novel Targeted Therapeutics.

@nl

prefLabel

Diffuse Intrinsic Pontine Glio ...... d Novel Targeted Therapeutics.

@en

Diffuse Intrinsic Pontine Glio ...... d Novel Targeted Therapeutics.

@nl

P1476

Diffuse Intrinsic Pontine Glio ...... d Novel Targeted Therapeutics.

@en

P2093

James T Rutka

http://www.w3.org/2001/XMLSchema#string

Ryan K Mathew

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas

K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas

Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas

Pre-Clinical Models of Diffuse Intrinsic Pontine Glioma

Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma

Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations

A pilot study of focused ultrasound thalamotomy for essential tremor

Importance of dose intensity in neuro-oncology clinical trials: summary report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium

In vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma

A high-throughput in vitro drug screen in a genetically engineered mouse model of diffuse intrinsic pontine glioma identifies BMS-754807 as a promising therapeutic agent

P304

343-351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3340/JKNS.2018.0008

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29742880

http://www.w3.org/2001/XMLSchema#string

P921

diffuse intrinsic pontine glioma

P932

5957322

http://www.w3.org/2001/XMLSchema#string